Showing results (1581-1590 of 1,612) with videos related to

Sort By:
Pageof 162
The Lancet. Respiratory Medicine|May 17, 2021
Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UKAnnemarie B Docherty, Rachel H Mulholland, Nazir I Lone, et al.
Nature Microbiology|February 9, 2023
Genetic mapping of microbial and host traits reveals production of immunomodulatory lipids by Akkermansia muciniphila in the murine gutQijun Zhang, Vanessa Linke, Katherine A Overmyer, et al.
The Lancet Regional Health. Europe|August 13, 2021
Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation ProtocolLouise Sigfrid, Thomas M Drake, Ellen Pauley, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2004
BMS-201620: a selective beta 3 agonistW N Washburn, C-Q Sun, G Bisacchi, et al.
RMD Open|February 11, 2026
Autoantibodies as predictors of progression to rheumatoid arthritis: a systematic review and meta-analysisSumera Qureshi, Maryam Adas, Phoebe J Cope, et al.
Circulation. Cardiovascular Genetics|March 31, 2015
Clinical Presentation, Long-Term Follow-Up, and Outcomes of 1001 Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Patients and Family MembersJudith A Groeneweg, Aditya Bhonsale, Cynthia A James, et al.
BMJ Open|March 11, 2021
What is the recovery rate and risk of long-term consequences following a diagnosis of COVID-19? A harmonised, global longitudinal observational study protocolLouise Sigfrid, Muge Cevik, Edwin Jesudason, et al.
Bioorganic & Medicinal Chemistry Letters|November 21, 2001
Beta 3 agonists. Part 1: evolution from inception to BMS-194449W N Washburn, P M Sher, K M Poss, et al.
Nature Communications|November 10, 2019
Author Correction: The future of Blue Carbon sciencePeter I Macreadie, Andrea Anton, John A Raven, et al.
Lancet (London, England)|July 18, 2021
Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort studyThomas M Drake, Aya M Riad, Cameron J Fairfield, et al.
Pageof 162